Summary
Boston Scientific Corporation (BSX) filed an 8-K on July 26, 2012, primarily to report its financial results for the second quarter ended June 30, 2012. The company issued a press release on July 26, 2012, detailing these results, which is furnished as an exhibit to this filing. Investors should refer to the press release (Exhibit 99.1) for specific financial performance metrics and commentary on the company's operations and financial condition during the quarter. This filing is procedural, serving as the official mechanism to disseminate the quarterly earnings information to the public via the SEC. While the 8-K itself does not contain the detailed financial data, it directs investors to the accompanying press release, which is the source for key figures such as revenue, earnings per share, and any forward-looking guidance or significant business updates discussed by management. It's important to note that the information provided in this 8-K and its exhibit is not considered 'filed' for the purposes of Section 18 of the Exchange Act, meaning the company may not face the same liability as it would for formally filed information.
Key Highlights
- 1Boston Scientific (BSX) announced its Q2 2012 financial results on July 26, 2012.
- 2The company filed an 8-K to report these earnings.
- 3The detailed financial results and operational commentary are provided in a press release, furnished as Exhibit 99.1.
- 4Investors need to review Exhibit 99.1 for specific Q2 2012 performance data.
- 5The filing serves as official notification of the quarterly results dissemination.
- 6Information is furnished, not 'filed' under Section 18 of the Exchange Act.